16th Oct 2018 9:30 am |
RNS |
Director/PDMR Shareholding |
16th Oct 2018 9:30 am |
RNS |
Director/PDMR Shareholding |
10th Oct 2018 3:30 pm |
RNS |
Director/PDMR Shareholding |
1st Oct 2018 1:58 pm |
RNS |
Total Voting Rights |
27th Sep 2018 4:35 pm |
RNS |
Director/PDMR Shareholding |
21st Sep 2018 12:30 pm |
RNS |
CHMP recommends expansion of Trelegy COPD label |
14th Sep 2018 9:00 am |
RNS |
ViiV submits HIV 2DR regulatory application to EMA |
12th Sep 2018 5:43 pm |
RNS |
Director/PDMR Shareholding |
10th Sep 2018 8:00 am |
RNS |
New analysis on efficacy of anti-IL5 biologics SEA |
10th Sep 2018 7:00 am |
RNS |
GSK receives CRL from FDA for mepolizumab in COPD |
7th Sep 2018 2:24 pm |
RNS |
Director/PDMR Shareholding |
7th Sep 2018 2:18 pm |
RNS |
Director/PDMR Shareholding |
3rd Sep 2018 5:00 pm |
RNS |
Total Voting Rights |
30th Aug 2018 5:12 pm |
RNS |
GSK publishes Q4 2018 Dividend Dates |
30th Aug 2018 8:12 am |
RNS |
EU approve Nucala in severe asthma in children |
24th Aug 2018 10:16 am |
RNS |
Director/PDMR Shareholding |
15th Aug 2018 7:00 am |
RNS |
Positive headline results for ViiV HC ATLAS study |
10th Aug 2018 3:00 pm |
RNS |
Director/PDMR Shareholding |
8th Aug 2018 12:35 pm |
RNS |
Director/PDMR Shareholding |
7th Aug 2018 7:00 am |
RNS |
Iain Mackay appointed GSK Chief Financial Officer |
2nd Aug 2018 5:07 pm |
RNS |
Publication of Base Prospectus |
2nd Aug 2018 11:04 am |
RNS |
Total Voting Rights |
31st Jul 2018 5:03 pm |
RNS |
Director/PDMR Shareholding |
31st Jul 2018 4:37 pm |
RNS |
Director/PDMR Shareholding |
27th Jul 2018 4:30 pm |
RNS |
Director/PDMR Shareholding |
27th Jul 2018 2:47 pm |
RNS |
CHMP recommend Nucala for severe asthma children |
26th Jul 2018 7:00 am |
RNS |
GSK reports on FDA Ad Com on mepolizumab for COPD |
25th Jul 2018 4:15 pm |
RNS |
Director/PDMR Shareholding |
25th Jul 2018 11:00 am |
RNS |
GSK and 23andMe Agreement |
25th Jul 2018 11:00 am |
RNS |
2nd Quarter Results |
24th Jul 2018 9:01 am |
RNS |
ViiV announces Juluca 100 week data at AIDS 2018 |
24th Jul 2018 9:00 am |
RNS |
ViiV shows positive phIII data on two-drug combo |
19th Jul 2018 4:45 pm |
RNS |
Director/PDMR Shareholding |
17th Jul 2018 5:46 pm |
RNS |
Director/PDMR Shareholding |
17th Jul 2018 4:54 pm |
RNS |
Director/PDMR Shareholding |
17th Jul 2018 4:49 pm |
RNS |
Director/PDMR Shareholding |
16th Jul 2018 2:51 pm |
RNS |
Director/PDMR Shareholding |
16th Jul 2018 11:11 am |
RNS |
Director/PDMR Shareholding |
13th Jul 2018 4:16 pm |
RNS |
Director/PDMR Shareholding |
13th Jul 2018 4:16 pm |
RNS |
Director/PDMR Shareholding |